Brown-Forman Reportedly Rebuffs Sazerac. What It Means for the Stock.

Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop